Palisade Bio (PALI) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -365.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -365.12% |
| Dec 31, 2025 | -194.92% |
| Sep 30, 2025 | 18.67% |
| Jun 30, 2025 | 32.47% |
| Mar 31, 2025 | 37.10% |
| Dec 31, 2024 | -7.19% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | -16.64% |
| Mar 31, 2024 | -45.27% |
| Dec 31, 2023 | 18.00% |
| Sep 30, 2023 | 14.29% |
| Jun 30, 2023 | -0.98% |
| Mar 31, 2023 | 34.97% |
| Dec 31, 2022 | 4.49% |
| Sep 30, 2022 | -45.20% |
| Jun 30, 2022 | 89.33% |
| Mar 31, 2022 | -6.23% |
| Dec 31, 2021 | -17.37% |
| Sep 30, 2021 | -65.66% |
| Jun 30, 2021 | -1,718.88% |
| Mar 31, 2021 | -84.93% |
| Dec 31, 2020 | -61.71% |
| Sep 30, 2020 | 13.01% |
| Jun 30, 2020 | 3.43% |
| Mar 31, 2020 | 18.51% |
| Dec 31, 2019 | -19.05% |
| Sep 30, 2019 | -2.14% |
| Jun 30, 2019 | 4.80% |
| Mar 31, 2019 | -4.13% |
| Dec 31, 2018 | 20.87% |
| Sep 30, 2018 | 19.63% |
| Jun 30, 2018 | 52.51% |
| Mar 31, 2018 | 46.36% |
| Dec 31, 2017 | 61.30% |
| Sep 30, 2017 | 49.98% |
| Jun 30, 2017 | -1.85% |
| Mar 31, 2017 | 34.18% |
| Dec 31, 2016 | -22.04% |
| Sep 30, 2016 | 8.82% |
| Jun 30, 2016 | 23.81% |
| Mar 31, 2016 | -30.79% |
| Dec 31, 2015 | 5.59% |
| Sep 30, 2015 | -26.54% |
| Jun 30, 2015 | -39.74% |
| Mar 31, 2015 | 9.52% |
| Dec 31, 2014 | -58.16% |
| Sep 30, 2014 | -9.62% |
| Jun 30, 2014 | -6.37% |
| Mar 31, 2014 | -90.60% |
| Dec 31, 2013 | -17.77% |
| Sep 30, 2013 | -57.64% |
| Jun 30, 2013 | -53.94% |
| Mar 31, 2013 | -19.34% |
| Dec 31, 2012 | -6.21% |
| Sep 30, 2012 | 19.73% |
| Jun 30, 2012 | 34.87% |
| Mar 31, 2012 | 30.12% |
| Dec 31, 2011 | -68.32% |
| Sep 30, 2011 | 17.79% |
| Jun 30, 2011 | 12.85% |